<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03793387</url>
  </required_header>
  <id_info>
    <org_study_id>107-097-F</org_study_id>
    <nct_id>NCT03793387</nct_id>
  </id_info>
  <brief_title>Intra-op vs Pre-op Transbronchial Localization for Small Lung Nodule</brief_title>
  <official_title>Preoperative Versus Intraoperative Transbronchial Dye Localization for Small Pulmonary Nodule : A Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital Hsin-Chu Branch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital Hsin-Chu Branch</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing pre-operative transbronchial localization under augmented fluoroscopy and
      intra-operative transbronchial localization using electromagnetic navigation bronchoscopy
      system for small lung nodules.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using electromagnetic navigation bronchoscopy (ENB), transbronchial localization can be
      performed in the operating room (OR) under general anesthesia without extra radiation
      exposure, which is expected to reduce the discomfort for the patient during localization.
      This study will be carried out at the Hsinchu Branch of National Taiwan University Hospital.
      It is expected that 40 patients with pulmonary nodules will be randomly assigned into two
      groups. One group will receive bronchoscopic dye localization in the hybrid examination room
      equipped with cone-beam computed tomography, and the other group will receive ENB-guided dye
      localization in OR. The primary goal of the study was to compare the localization duration of
      the two groups of patients, the total dose of radiation exposure during localization and the
      incidence of location-related complications, and the secondary goals were the results of the
      surgical procedure, including the surgical duration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 8, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful localization</measure>
    <time_frame>2 days</time_frame>
    <description>Discrepancy from lesion to marking: less than 1 cm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Successful resection</measure>
    <time_frame>2 days</time_frame>
    <description>Lesion contained in first resected specimen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Localization duration</measure>
    <time_frame>1 day</time_frame>
    <description>Total time span of localization procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total radiation exposure</measure>
    <time_frame>2 days</time_frame>
    <description>Radiation during entire localization procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication</measure>
    <time_frame>14 days</time_frame>
    <description>Procedure related complication</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Pre-op</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Intra-op</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AF-guided endobronchial marking</intervention_name>
    <description>Bronchoscopic dye marking under CBCT-augmented fluoroscopic guidance</description>
    <arm_group_label>Pre-op</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ENB-guided endobronchial marking</intervention_name>
    <description>Bronchoscopic dye marking with ENB system</description>
    <arm_group_label>Intra-op</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A. One of each: lung nodule size less than 1 cm; depth more than 2 cm; GGO lesion B. 20~90
        years old C. sign permit

        Exclusion Criteria:

        A. Previous emphysema, TB, COPD B. Previous ipsilateral thoracic surgery C. Bleeding
        tendency D. Heart failure, cirrhosis, CKD E. Pregnancy or breast feeding F.
        Immunocompromised G. Severe infection H. Unable to sign permit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shun-Mao Yang, MD</last_name>
    <phone>+886-972-654-475</phone>
    <email>mutayang@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital, Hsin-Chu Branch</name>
      <address>
        <city>Taipei</city>
        <state>Hsin-Chu County</state>
        <zip>30059</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiu-kuei Nien</last_name>
      <phone>886-3-5326151</phone>
      <email>hch01215@hch.gov.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 2, 2019</study_first_submitted>
  <study_first_submitted_qc>January 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 4, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

